Semnur Pharmaceuticals, Inc. (SMNRW)
OTC: SMNRW · CIK 0001913577 · United States
Every official Semnur Pharmaceuticals, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open SMNRW filings
Semnur Pharmaceuticals, Inc. documents
- Semnur Pharmaceuticals, Inc. 10-K 2026SMNRW 10-K 2026: annual report for fiscal 2026
- Semnur Pharmaceuticals, Inc. 10-K 2025SMNRW 10-K 2025: annual report for fiscal 2025
- Semnur Pharmaceuticals, Inc. 10-K 2024SMNRW 10-K 2024: annual report for fiscal 2024
- Semnur Pharmaceuticals, Inc. 10-K 2023SMNRW 10-K 2023: annual report for fiscal 2023
- Semnur Pharmaceuticals, Inc. 10-K 2022SMNRW 10-K 2022: annual report for fiscal 2022
- Semnur Pharmaceuticals, Inc. 10-Q 2026SMNRW 10-Q 2026: quarterly report for fiscal 2026
- Semnur Pharmaceuticals, Inc. 10-Q 2025SMNRW 10-Q 2025: quarterly report for fiscal 2025
- Semnur Pharmaceuticals, Inc. 10-Q 2024SMNRW 10-Q 2024: quarterly report for fiscal 2024
- Semnur Pharmaceuticals, Inc. 10-Q 2023SMNRW 10-Q 2023: quarterly report for fiscal 2023
- Semnur Pharmaceuticals, Inc. 10-Q 2022SMNRW 10-Q 2022: quarterly report for fiscal 2022
- Semnur Pharmaceuticals, Inc. 8-K 2026SMNRW 8-K 2026: current report for fiscal 2026
- Semnur Pharmaceuticals, Inc. 8-K 2025SMNRW 8-K 2025: current report for fiscal 2025
- Semnur Pharmaceuticals, Inc. 8-K 2024SMNRW 8-K 2024: current report for fiscal 2024
- Semnur Pharmaceuticals, Inc. 8-K 2023SMNRW 8-K 2023: current report for fiscal 2023
- Semnur Pharmaceuticals, Inc. 8-K 2022SMNRW 8-K 2022: current report for fiscal 2022
- Semnur Pharmaceuticals, Inc. DEF 14A 2026SMNRW DEF 14A 2026: proxy statement for fiscal 2026
- Semnur Pharmaceuticals, Inc. DEF 14A 2025SMNRW DEF 14A 2025: proxy statement for fiscal 2025
- Semnur Pharmaceuticals, Inc. DEF 14A 2024SMNRW DEF 14A 2024: proxy statement for fiscal 2024
- Semnur Pharmaceuticals, Inc. DEF 14A 2023SMNRW DEF 14A 2023: proxy statement for fiscal 2023
- Semnur Pharmaceuticals, Inc. DEF 14A 2022SMNRW DEF 14A 2022: proxy statement for fiscal 2022
- Semnur Pharmaceuticals, Inc. Form 4 2026SMNRW Form 4 2026: insider trading filing for fiscal 2026
- Semnur Pharmaceuticals, Inc. Form 4 2025SMNRW Form 4 2025: insider trading filing for fiscal 2025
- Semnur Pharmaceuticals, Inc. Form 4 2024SMNRW Form 4 2024: insider trading filing for fiscal 2024
- Semnur Pharmaceuticals, Inc. Form 4 2023SMNRW Form 4 2023: insider trading filing for fiscal 2023
- Semnur Pharmaceuticals, Inc. Form 4 2022SMNRW Form 4 2022: insider trading filing for fiscal 2022
- Semnur Pharmaceuticals, Inc. S-1 2026SMNRW S-1 2026: registration statement for fiscal 2026
- Semnur Pharmaceuticals, Inc. S-1 2025SMNRW S-1 2025: registration statement for fiscal 2025
- Semnur Pharmaceuticals, Inc. S-1 2024SMNRW S-1 2024: registration statement for fiscal 2024
- Semnur Pharmaceuticals, Inc. S-1 2023SMNRW S-1 2023: registration statement for fiscal 2023
- Semnur Pharmaceuticals, Inc. S-1 2022SMNRW S-1 2022: registration statement for fiscal 2022
- Semnur Pharmaceuticals, Inc. 13F 2026SMNRW 13F 2026: institutional holdings for fiscal 2026
- Semnur Pharmaceuticals, Inc. 13F 2025SMNRW 13F 2025: institutional holdings for fiscal 2025
- Semnur Pharmaceuticals, Inc. 13F 2024SMNRW 13F 2024: institutional holdings for fiscal 2024
- Semnur Pharmaceuticals, Inc. 13F 2023SMNRW 13F 2023: institutional holdings for fiscal 2023
- Semnur Pharmaceuticals, Inc. 13F 2022SMNRW 13F 2022: institutional holdings for fiscal 2022
More companies